← All companies

DYN

Dyne Therapeutics, Inc.

DYN Nasdaq Pharmaceutical Preparations EDGAR ↗

$25.24

+0.06 +0.24%

Key statistics

from XBRL data in SEC filings

Market cap

$4.71B

Revenue (TTM)

—

Net income (TTM)

-$73.2M

EPS (TTM)

$-3.26

P/E ratio

—

Dividend yield

—

Free cash flow

-$405M

Cash

$676M

Total assets

$994M

Gross margin

—

52-week range

$9.89 – $26.26

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release) Jul 29, 2026 10-Q Quarter ended 2026-06-30 Jul 29, 2026 8-K Entered a material agreement; Other events Jul 22, 2026 8-K Other events Jul 20, 2026 8-K Director or officer change Jun 22, 2026 8-K Entered a material agreement; Took on a direct financial obligation Jun 17, 2026 8-K Shareholder vote results Jun 8, 2026 8-K Regulation FD disclosure; Other events Jun 3, 2026 8-K Results of operations (earnings release) May 11, 2026 10-Q Quarter ended 2026-03-31 May 11, 2026 8-K Results of operations (earnings release) Mar 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Director or officer change Dec 23, 2025 8-K Entered a material agreement; Other events Dec 10, 2025 8-K Took on a direct financial obligation Dec 8, 2025 8-K Regulation FD disclosure; Other events Dec 8, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Director or officer change Oct 2, 2025 8-K Regulation FD disclosure; Other events Aug 4, 2025 8-K Results of operations (earnings release) Jul 28, 2025 10-Q Quarter ended 2025-06-30 Jul 28, 2025 8-K Entered a material agreement; Other events Jul 1, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 30, 2025 8-K Regulation FD disclosure; Other events Jun 17, 2025 8-K Shareholder vote results Jun 5, 2025 8-K Results of operations (earnings release) May 8, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Director or officer change Mar 20, 2025 8-K Results of operations (earnings release) Feb 27, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 10, 2025 8-K Other events Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Director or officer change; Regulation FD disclosure; Other events Sep 3, 2024 8-K Results of operations (earnings release) Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results May 24, 2024